Team:EPF-Lausanne/Our Project/TetR mutants

From 2011.igem.org

(Difference between revisions)
(Background information about TetR)
Line 1: Line 1:
{{:Team:EPF-Lausanne/Templates/TetRtemplate|title=Intro}}
{{:Team:EPF-Lausanne/Templates/TetRtemplate|title=Intro}}
-
to write here: how we got TetR mutants, with which method (we can also explain the method in the "tools" section)
+
The choice of the trial transcription factor for the pipeline developpement was made ....
-
The MITOMI characterization will be explained in the "tool" section?
+
== Background Information about TetR ==
== Background Information about TetR ==
Line 20: Line 19:
The impact of one or several amino acids changes on the binding strength and specificity is less known. Amino acids in direct proximity to or the residues binding DNA are probably crucial - but more distant amino acids could also have an influence due to allosteric effects. Some TetR mutants that have an altered recognition sequence have been characterized in the literature.
The impact of one or several amino acids changes on the binding strength and specificity is less known. Amino acids in direct proximity to or the residues binding DNA are probably crucial - but more distant amino acids could also have an influence due to allosteric effects. Some TetR mutants that have an altered recognition sequence have been characterized in the literature.
-
Lilia, please add a list... I have 4C, 6C (Helbl) and double from Krueger
+
 
 +
The effects of the mutations V36F, E37A, P39K and Y42F were described
 +
 
{{:Team:EPF-Lausanne/Templates/Footer}}
{{:Team:EPF-Lausanne/Templates/Footer}}

Revision as of 00:05, 22 September 2011